<?xml version="1.0" encoding="UTF-8"?>
<eudamedExport entity="devices">
  <row>
    <udiDi>+G306P737</udiDi>
    <basicUdiDi>++G306P7A2</basicUdiDi>
    <tradeName>Kryo Systeme IIa</tradeName>
    <deviceName></deviceName>
    <manufacturerName>Consarctic GmbH</manufacturerName>
    <manufacturerSrn>DE-PR-000020486</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf IIa</riskClass>
    <legislation>MDR 2017/745</legislation>
    <emdnCode>V0902</emdnCode>
    <emdnDescription>CLINICAL/THERAPEUTIC APPLICATIONS LIQUID NITROGEN</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>BSD450+</reference>
    <placedOnMarketCountry></placedOnMarketCountry>
    <lastUpdated>2026-06-21T21:03:47.902Z</lastUpdated>
  </row>
  <row>
    <udiDi>+G306P738</udiDi>
    <basicUdiDi>++G306P7A2</basicUdiDi>
    <tradeName>Kryo Systeme IIa</tradeName>
    <deviceName></deviceName>
    <manufacturerName>Consarctic GmbH</manufacturerName>
    <manufacturerSrn>DE-PR-000020486</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf IIa</riskClass>
    <legislation>MDR 2017/745</legislation>
    <emdnCode>V0902</emdnCode>
    <emdnDescription>CLINICAL/THERAPEUTIC APPLICATIONS LIQUID NITROGEN</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>BSD550+</reference>
    <placedOnMarketCountry></placedOnMarketCountry>
    <lastUpdated>2026-06-21T21:03:47.876Z</lastUpdated>
  </row>
  <row>
    <udiDi>+G306P739</udiDi>
    <basicUdiDi>++G306P7A2</basicUdiDi>
    <tradeName>Kryo Systeme IIa</tradeName>
    <deviceName></deviceName>
    <manufacturerName>Consarctic GmbH</manufacturerName>
    <manufacturerSrn>DE-PR-000020486</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf IIa</riskClass>
    <legislation>MDR 2017/745</legislation>
    <emdnCode>V0902</emdnCode>
    <emdnDescription>CLINICAL/THERAPEUTIC APPLICATIONS LIQUID NITROGEN</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>BSD750+</reference>
    <placedOnMarketCountry></placedOnMarketCountry>
    <lastUpdated>2026-06-21T21:03:47.849Z</lastUpdated>
  </row>
  <row>
    <udiDi>+G306P741</udiDi>
    <basicUdiDi>++G306P7A2</basicUdiDi>
    <tradeName>Kryo Systeme IIa</tradeName>
    <deviceName></deviceName>
    <manufacturerName>Consarctic GmbH</manufacturerName>
    <manufacturerSrn>DE-PR-000020486</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf IIa</riskClass>
    <legislation>MDR 2017/745</legislation>
    <emdnCode>V0902</emdnCode>
    <emdnDescription>CLINICAL/THERAPEUTIC APPLICATIONS LIQUID NITROGEN</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>BSD950+</reference>
    <placedOnMarketCountry></placedOnMarketCountry>
    <lastUpdated>2026-06-21T21:03:47.825Z</lastUpdated>
  </row>
  <row>
    <udiDi>+G306P742</udiDi>
    <basicUdiDi>++G306P7A2</basicUdiDi>
    <tradeName>Kryo Systeme IIa</tradeName>
    <deviceName></deviceName>
    <manufacturerName>Consarctic GmbH</manufacturerName>
    <manufacturerSrn>DE-PR-000020486</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf IIa</riskClass>
    <legislation>MDR 2017/745</legislation>
    <emdnCode>V0902</emdnCode>
    <emdnDescription>CLINICAL/THERAPEUTIC APPLICATIONS LIQUID NITROGEN</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>BSD1050+</reference>
    <placedOnMarketCountry></placedOnMarketCountry>
    <lastUpdated>2026-06-21T21:03:47.805Z</lastUpdated>
  </row>
  <row>
    <udiDi>+G306P743</udiDi>
    <basicUdiDi>++G306P7A2</basicUdiDi>
    <tradeName>Kryo Systeme IIa</tradeName>
    <deviceName></deviceName>
    <manufacturerName>Consarctic GmbH</manufacturerName>
    <manufacturerSrn>DE-PR-000020486</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf IIa</riskClass>
    <legislation>MDR 2017/745</legislation>
    <emdnCode>V0902</emdnCode>
    <emdnDescription>CLINICAL/THERAPEUTIC APPLICATIONS LIQUID NITROGEN</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>BSD1250+</reference>
    <placedOnMarketCountry></placedOnMarketCountry>
    <lastUpdated>2026-06-21T21:03:47.778Z</lastUpdated>
  </row>
  <row>
    <udiDi>+G306P744</udiDi>
    <basicUdiDi>++G306P7A2</basicUdiDi>
    <tradeName>Kryo Systeme IIa</tradeName>
    <deviceName></deviceName>
    <manufacturerName>Consarctic GmbH</manufacturerName>
    <manufacturerSrn>DE-PR-000020486</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf IIa</riskClass>
    <legislation>MDR 2017/745</legislation>
    <emdnCode>V0902</emdnCode>
    <emdnDescription>CLINICAL/THERAPEUTIC APPLICATIONS LIQUID NITROGEN</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>BSD1450+</reference>
    <placedOnMarketCountry></placedOnMarketCountry>
    <lastUpdated>2026-06-21T21:03:47.759Z</lastUpdated>
  </row>
  <row>
    <udiDi>+G306P745</udiDi>
    <basicUdiDi>++G306P7A2</basicUdiDi>
    <tradeName>Kryo Systeme IIa</tradeName>
    <deviceName></deviceName>
    <manufacturerName>Consarctic GmbH</manufacturerName>
    <manufacturerSrn>DE-PR-000020486</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf IIa</riskClass>
    <legislation>MDR 2017/745</legislation>
    <emdnCode>V0902</emdnCode>
    <emdnDescription>CLINICAL/THERAPEUTIC APPLICATIONS LIQUID NITROGEN</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>BSD2950+</reference>
    <placedOnMarketCountry></placedOnMarketCountry>
    <lastUpdated>2026-06-21T21:03:47.739Z</lastUpdated>
  </row>
  <row>
    <udiDi>+G306P746</udiDi>
    <basicUdiDi>++G306P7A2</basicUdiDi>
    <tradeName>Kryo Systeme IIa</tradeName>
    <deviceName></deviceName>
    <manufacturerName>Consarctic GmbH</manufacturerName>
    <manufacturerSrn>DE-PR-000020486</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf IIa</riskClass>
    <legislation>MDR 2017/745</legislation>
    <emdnCode>V0902</emdnCode>
    <emdnDescription>CLINICAL/THERAPEUTIC APPLICATIONS LIQUID NITROGEN</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>BSR420+</reference>
    <placedOnMarketCountry></placedOnMarketCountry>
    <lastUpdated>2026-06-21T21:03:47.727Z</lastUpdated>
  </row>
  <row>
    <udiDi>+G306P747</udiDi>
    <basicUdiDi>++G306P7A2</basicUdiDi>
    <tradeName>Kryo Systeme IIa</tradeName>
    <deviceName></deviceName>
    <manufacturerName>Consarctic GmbH</manufacturerName>
    <manufacturerSrn>DE-PR-000020486</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf IIa</riskClass>
    <legislation>MDR 2017/745</legislation>
    <emdnCode>V0902</emdnCode>
    <emdnDescription>CLINICAL/THERAPEUTIC APPLICATIONS LIQUID NITROGEN</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>BSR420R+</reference>
    <placedOnMarketCountry></placedOnMarketCountry>
    <lastUpdated>2026-06-21T21:03:47.716Z</lastUpdated>
  </row>
  <row>
    <udiDi>+G306P748</udiDi>
    <basicUdiDi>++G306P7A2</basicUdiDi>
    <tradeName>Kryo Systeme IIa</tradeName>
    <deviceName></deviceName>
    <manufacturerName>Consarctic GmbH</manufacturerName>
    <manufacturerSrn>DE-PR-000020486</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf IIa</riskClass>
    <legislation>MDR 2017/745</legislation>
    <emdnCode>V0902</emdnCode>
    <emdnDescription>CLINICAL/THERAPEUTIC APPLICATIONS LIQUID NITROGEN</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>ABV4+</reference>
    <placedOnMarketCountry></placedOnMarketCountry>
    <lastUpdated>2026-06-21T21:03:47.697Z</lastUpdated>
  </row>
  <row>
    <udiDi>+G306P749</udiDi>
    <basicUdiDi>++G306P7A2</basicUdiDi>
    <tradeName>Kryo Systeme IIa</tradeName>
    <deviceName></deviceName>
    <manufacturerName>Consarctic GmbH</manufacturerName>
    <manufacturerSrn>DE-PR-000020486</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf IIa</riskClass>
    <legislation>MDR 2017/745</legislation>
    <emdnCode>V0902</emdnCode>
    <emdnDescription>CLINICAL/THERAPEUTIC APPLICATIONS LIQUID NITROGEN</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>ABSA48+</reference>
    <placedOnMarketCountry></placedOnMarketCountry>
    <lastUpdated>2026-06-21T21:03:47.675Z</lastUpdated>
  </row>
  <row>
    <udiDi>+G306P750</udiDi>
    <basicUdiDi>++G306P7A2</basicUdiDi>
    <tradeName>Kryo Systeme IIa</tradeName>
    <deviceName></deviceName>
    <manufacturerName>Consarctic GmbH</manufacturerName>
    <manufacturerSrn>DE-PR-000020486</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf IIa</riskClass>
    <legislation>MDR 2017/745</legislation>
    <emdnCode>V0902</emdnCode>
    <emdnDescription>CLINICAL/THERAPEUTIC APPLICATIONS LIQUID NITROGEN</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>ASR4D+</reference>
    <placedOnMarketCountry></placedOnMarketCountry>
    <lastUpdated>2026-06-21T21:03:47.662Z</lastUpdated>
  </row>
  <row>
    <udiDi>+G306P771</udiDi>
    <basicUdiDi>++G306P7A2</basicUdiDi>
    <tradeName>Kryo Systeme IIa</tradeName>
    <deviceName></deviceName>
    <manufacturerName>Consarctic GmbH</manufacturerName>
    <manufacturerSrn>DE-PR-000020486</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf IIa</riskClass>
    <legislation>MDR 2017/745</legislation>
    <emdnCode>V0902</emdnCode>
    <emdnDescription>CLINICAL/THERAPEUTIC APPLICATIONS LIQUID NITROGEN</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>Kryo Systeme mit Behältern verschiedener Typen</reference>
    <placedOnMarketCountry></placedOnMarketCountry>
    <lastUpdated>2026-06-21T21:03:47.632Z</lastUpdated>
  </row>
  <row>
    <udiDi>05902768134193</udiDi>
    <basicUdiDi>B-05902768134193</basicUdiDi>
    <tradeName>MESSERMEDLINE-LAPCO2</tradeName>
    <deviceName></deviceName>
    <manufacturerName>Messer Polska Sp. z o.o.</manufacturerName>
    <manufacturerSrn>PL-MF-000001609</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf IIa</riskClass>
    <legislation>UNKNOWN</legislation>
    <emdnCode>V0901</emdnCode>
    <emdnDescription>CLINICAL/THERAPEUTIC APPLICATIONS CARBON DIOXIDE</emdnDescription>
    <deviceStatus>Artık piyasada değil</deviceStatus>
    <reference>103100082</reference>
    <placedOnMarketCountry>Czechia</placedOnMarketCountry>
    <lastUpdated>2026-06-21T14:28:17.796Z</lastUpdated>
  </row>
  <row>
    <udiDi>05902768134162</udiDi>
    <basicUdiDi>B-05902768134162</basicUdiDi>
    <tradeName>MESSERMEDLINE - LAPCO2</tradeName>
    <deviceName></deviceName>
    <manufacturerName>Messer Polska Sp. z o.o.</manufacturerName>
    <manufacturerSrn>PL-MF-000001609</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf IIa</riskClass>
    <legislation>UNKNOWN</legislation>
    <emdnCode>V0901</emdnCode>
    <emdnDescription>CLINICAL/THERAPEUTIC APPLICATIONS CARBON DIOXIDE</emdnDescription>
    <deviceStatus>Artık piyasada değil</deviceStatus>
    <reference>103100272</reference>
    <placedOnMarketCountry>Czechia</placedOnMarketCountry>
    <lastUpdated>2026-06-21T14:28:16.536Z</lastUpdated>
  </row>
  <row>
    <udiDi>05902768134155</udiDi>
    <basicUdiDi>B-05902768134155</basicUdiDi>
    <tradeName>MESSERMEDLINE LAPCO2</tradeName>
    <deviceName></deviceName>
    <manufacturerName>Messer Polska Sp. z o.o.</manufacturerName>
    <manufacturerSrn>PL-MF-000001609</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf IIa</riskClass>
    <legislation>UNKNOWN</legislation>
    <emdnCode>V0901</emdnCode>
    <emdnDescription>CLINICAL/THERAPEUTIC APPLICATIONS CARBON DIOXIDE</emdnDescription>
    <deviceStatus>Artık piyasada değil</deviceStatus>
    <reference>103100502</reference>
    <placedOnMarketCountry>Poland</placedOnMarketCountry>
    <lastUpdated>2026-06-21T14:28:14.138Z</lastUpdated>
  </row>
  <row>
    <udiDi>05902768134148</udiDi>
    <basicUdiDi>B-05902768134148</basicUdiDi>
    <tradeName>MESSERMEDLINE LAPCO2</tradeName>
    <deviceName></deviceName>
    <manufacturerName>Messer Polska Sp. z o.o.</manufacturerName>
    <manufacturerSrn>PL-MF-000001609</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf IIa</riskClass>
    <legislation>UNKNOWN</legislation>
    <emdnCode>V0901</emdnCode>
    <emdnDescription>CLINICAL/THERAPEUTIC APPLICATIONS CARBON DIOXIDE</emdnDescription>
    <deviceStatus>Artık piyasada değil</deviceStatus>
    <reference>103105812</reference>
    <placedOnMarketCountry>Poland</placedOnMarketCountry>
    <lastUpdated>2026-06-21T14:28:12.989Z</lastUpdated>
  </row>
  <row>
    <udiDi>05902768134131</udiDi>
    <basicUdiDi>B-05902768134131</basicUdiDi>
    <tradeName>MESSERMEDLINE – LAPCO2</tradeName>
    <deviceName></deviceName>
    <manufacturerName>Messer Polska Sp. z o.o.</manufacturerName>
    <manufacturerSrn>PL-MF-000001609</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf IIa</riskClass>
    <legislation>UNKNOWN</legislation>
    <emdnCode>V0901</emdnCode>
    <emdnDescription>CLINICAL/THERAPEUTIC APPLICATIONS CARBON DIOXIDE</emdnDescription>
    <deviceStatus>Artık piyasada değil</deviceStatus>
    <reference>103100102</reference>
    <placedOnMarketCountry>Poland</placedOnMarketCountry>
    <lastUpdated>2026-06-21T14:28:11.814Z</lastUpdated>
  </row>
  <row>
    <udiDi>05902768134124</udiDi>
    <basicUdiDi>B-05902768134124</basicUdiDi>
    <tradeName>MESSERMEDLINE CRYOCO2</tradeName>
    <deviceName></deviceName>
    <manufacturerName>Messer Polska Sp. z o.o.</manufacturerName>
    <manufacturerSrn>PL-MF-000001609</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf IIa</riskClass>
    <legislation>UNKNOWN</legislation>
    <emdnCode>V0901</emdnCode>
    <emdnDescription>CLINICAL/THERAPEUTIC APPLICATIONS CARBON DIOXIDE</emdnDescription>
    <deviceStatus>Artık piyasada değil</deviceStatus>
    <reference>103106502</reference>
    <placedOnMarketCountry>Poland</placedOnMarketCountry>
    <lastUpdated>2026-06-21T14:28:10.616Z</lastUpdated>
  </row>
</eudamedExport>